UPCOMING WEBINAR

Pharma R&D Review Live 2026

April 21 | 10am NYC | 3pm LDN

Join our experts as they dig deep into the latest global drug development trends, cultivating insight into the companies investing most heavily in R&D and uncovering which therapeutic areas are truly flourishing.

From early seeds of innovation to late‑stage successes, we’ll explore what’s taking root across the pipeline — and what's set to bloom next.

  • Explore the size and shape of the 2026 global drug pipeline, from early discovery seeds to late‑stage growth
  • Review key drug launches and success stories from 2025 that have borne fruit
  • See which companies, therapies, and targets are leading R&D and gaining ground
  • Get expert picks for the most anticipated drug approvals set to blossom in 2026
Citeline may contact you about relevant products, services, and content. To opt out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.

Featured speakers

Headshot of Ian Lloyd.

IAN LLOYD

Senior Director for Pharmaprojects

For 33 years, Ian has been the chief author of the annual Pharma R&D Review. His data-driven insights and unique perspective are a staple in the pharmaceutical calendar. Our webinar is your opportunity to put your questions directly to Ian, and uncover new insights that could unlock your future strategy.

Headshot of Alexandra Shimmings.

ALEX SHIMMINGS

Executive Editor, Scrip

As the head of our European editorial team, Alex has covered breakthroughs in R&D across a range of therapeutic areas, including infectious diseases, cardiology, and cancer. She frequently interviews key players in the industry, keeping her finger on the pulse of the global pharma R&D landscape.